ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SYBX Synlogic Inc

1.91
0.07 (3.80%)
Apr 23 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Synlogic Inc SYBX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 3.80% 1.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.85 1.85 1.96 1.91 1.84
more quote information »

Recent News

Date Time Source Heading
3/19/202407:00GLOBESynlogic Reports Fourth Quarter and Full Year 2023 Financial..
2/22/202416:37EDGAR2Form 8-K - Current report
2/20/202417:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
2/20/202416:06EDGAR2Form 8-K - Current report
2/20/202412:15GLOBESynlogic Adopts Limited Duration Stockholders Rights Plan
2/16/202416:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/16/202416:44EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2/14/202415:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202416:00EDGAR2Form 8-K - Current report
2/08/202416:15GLOBESynlogic Announces Decision to Discontinue Synpheny-3 Study..
2/02/202412:00GLOBESynlogic Announces Publication of Preclinical and Clinical..
1/04/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202407:00GLOBESynlogic Provides Corporate Update and Outlook for 2024
12/29/202316:00EDGAR2Form 8-K - Current report
12/27/202307:00GLOBESynlogic Announces Contract with the Air Force Research Lab
12/07/202307:00GLOBESynlogic Announces Abstract Accepted for Poster Presentation..
11/17/202316:00EDGAR2Form 8-K - Current report
11/14/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202307:00GLOBESynlogic Reports Third Quarter 2023 Financial Results and..
11/09/202306:44EDGAR2Form 8-K - Current report
11/09/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:00GLOBESynlogic Achieves Research Milestone and Earns $2.5 Million..
11/07/202306:45EDGAR2Form 8-K - Current report
10/13/202316:17EDGAR2Form SC 13D/A - General statement of acquisition of..
10/03/202316:15GLOBESynlogic Announces Closing of $21.0 Million Underwritten..
10/02/202317:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
9/29/202308:53EDGAR2Form 8-K - Current report
9/29/202307:00GLOBESynlogic Announces Pricing of $21.0 Million Underwritten..
9/28/202321:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
9/28/202316:15EDGAR2Form 8-K - Current report
9/28/202311:15GLOBESynlogic Announces Publication of Synpheny-1 Phase 2 Study..
9/28/202308:39EDGAR2Form S-1/A - General form for registration of securities..
9/27/202312:30GLOBESynlogic Announces Reverse Stock Split
9/26/202321:41EDGAR2Form S-1/A - General form for registration of securities..
9/22/202316:15EDGAR2Form 8-K - Current report
9/21/202307:00GLOBESynlogic to Participate in Chardan’s Genetic Medicines..
9/19/202311:00GLOBESynlogic Announces CEO Aoife Brennan Named to PharmaVoice..
9/08/202316:06EDGAR2Form S-1 - General form for registration of securities under..
9/01/202308:00EDGAR2Form DEF 14A - Other definitive proxy statements
8/21/202317:15EDGAR2Form PRE 14A - Other preliminary proxy statements
8/16/202316:05EDGAR2Form 8-K - Current report
8/10/202307:00GLOBESynlogic Reports Second Quarter 2023 Financial Results and..
8/10/202306:35EDGAR2Form 8-K - Current report
8/10/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/11/202307:00GLOBESynlogic Granted Fast Track Designation from FDA for..
6/28/202307:00GLOBESynlogic Announces International Nonproprietary Name..
6/27/202307:00GLOBESynlogic Announces Participation in SVB Securities..
6/08/202306:45GLOBESynlogic Reminds Stockholders of 2023 Annual General Meeting..

Your Recent History

Delayed Upgrade Clock